Jason Adelman

Jason Adelman is a seasoned professional with significant experience in leadership roles across various companies. Currently serving as Managing Partner at Burnham Hill Capital Group LLC, Jason Adelman is also a member of the Board of Directors at Trio-Tech International and has held a position as Special Advisor to the Board at AzurRx BioPharma, Inc. from 2015 to March 2019. Additionally, Jason Adelman served on the Board of Directors at Pharmacyclics from 2008 to 2010, where Jason was Chairman of the Audit and Compensation Committee. Jason Adelman's educational background includes a Doctor of Law (JD) from Cornell Law School, a Bachelor of Arts in Economics from the University of Pennsylvania, and education from The Lawrenceville School.